| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
7e-12 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.21 |
8e-06 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
4e-05 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
| mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |